Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway. [electronic resource]
Producer: 20121119Description: 353-62 p. digitalISSN:- 1521-2254
- Animals
- Antigens, Neoplasm -- genetics
- CD8-Positive T-Lymphocytes
- Cancer Vaccines -- administration & dosage
- Carcinoma, Lewis Lung -- genetics
- Chorionic Gonadotropin, beta Subunit, Human -- genetics
- Epitopes -- genetics
- Female
- Genetic Vectors -- administration & dosage
- HEK293 Cells
- Humans
- Immunity, Active -- genetics
- Inhibitor of Apoptosis Proteins -- genetics
- Lysosomal Membrane Proteins -- genetics
- Major Histocompatibility Complex -- genetics
- Mice
- Mice, Inbred C57BL
- Survivin
- T-Lymphocytes, Cytotoxic -- immunology
- Vaccines, DNA -- administration & dosage
- Vascular Endothelial Growth Factor Receptor-2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.